Company intelligence / Profile preview

Kingsway Pharmaceuticals

Bristol, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

Kingsway Pharmaceuticals is a commercial-stage company focused on over-the-counter and consumer health products. Its PBZ OTC antihistamine cream, launched in 2025, was recognized as a Product of the Year winner and is available nationally in US retail stores. Other brands include Blue-Emu (topical analgesic), e.p.t. (pregnancy test), and Bikini Zone (hair removal care).

Therapeutic areas: Women's HealthDermatologyRheumatology
Modalities: Small moleculeTopical creamDevice
Industry: Biotech

Beyond the preview

Go deeper on Kingsway Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kingsway Pharmaceuticals.

Explore the full profile